{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:53:37Z","timestamp":1785192817758,"version":"3.55.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["LJ212510164014"],"award-info":[{"award-number":["LJ212510164014"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cyto.2025.157090","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T23:33:59Z","timestamp":1765582439000},"page":"157090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["SMAD signaling in cancer: integrative roles in tumor progression, immune evasion, and therapeutic resistance"],"prefix":"10.1016","volume":"198","author":[{"given":"Hai","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s13167-025-00407-6","article-title":"Targeting the MAPK signaling pathway: implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patients","volume":"16","author":"Kubatka","year":"2025","journal-title":"Epma j"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGF\u03b2 biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.cyto.2025.157090_bb0015","doi-asserted-by":"crossref","unstructured":"H. Mao, X. Zhao, S.-c. Sun, NF-\u03baB in inflammation and cancer, Cellular & Molecular Immunology (2025).","DOI":"10.1038\/s41423-025-01310-w"},{"issue":"12","key":"10.1016\/j.cyto.2025.157090_bb0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022277","article-title":"TGF-\u03b2 Family Signaling in Tumor Suppression and Cancer Progression","volume":"9","author":"Seoane","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"22","key":"10.1016\/j.cyto.2025.157090_bb0025","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1158\/0008-5472.CAN-08-2556","article-title":"Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer?","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.cyto.2025.157090_bb0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ccr.2012.08.013","article-title":"Dependency of colorectal cancer on a TGF-\u03b2-driven program in stromal cells for metastasis initiation","volume":"22","author":"Calon","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cyto.2025.157090_bb0035","article-title":"High Expression of TGF-\u03b21 Contributes to Hepatocellular Carcinoma Prognosis via Regulating Tumor Immunity","volume":"12","author":"Jin","year":"2022","journal-title":"Front Oncol"},{"issue":"5\u20136","key":"10.1016\/j.cyto.2025.157090_bb0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cytogfr.2009.10.010","article-title":"Smad signaling in skeletal development and regeneration","volume":"20","author":"Song","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41422-023-00918-9","article-title":"The roles and regulatory mechanisms of TGF-\u03b2 and BMP signaling in bone and cartilage development, homeostasis and disease","volume":"34","author":"Wu","year":"2024","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0055","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022145","article-title":"TGF-\u03b2 Family Signaling in the Control of Cell Proliferation and Survival","volume":"9","author":"Zhang","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s43556-022-00109-9","article-title":"TGF-beta signal transduction: biology, function and therapy for diseases","volume":"3","author":"Tie","year":"2022","journal-title":"Mol Biomed"},{"key":"10.1016\/j.cyto.2025.157090_bb0065","doi-asserted-by":"crossref","first-page":"1580500","DOI":"10.3389\/fphar.2025.1580500","article-title":"Dual signaling pathways of TGF-\u03b2 superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression","volume":"16","author":"Chaudhary","year":"2025","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.cyto.2025.157090_bb0070","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s12276-025-01483-4","article-title":"TGF-\u03b2 inhibition restores hematopoiesis and immune balance via bone marrow EPCs in aplastic anemia","volume":"57","author":"Zhang","year":"2025","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.cyto.2025.157090_bb0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-beta signal transduction","volume":"67","author":"Massagu\u00e9","year":"1998","journal-title":"Annu Rev Biochem"},{"issue":"22","key":"10.1016\/j.cyto.2025.157090_bb0080","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1242\/dev.030338","article-title":"The regulation of TGFbeta signal transduction","volume":"136","author":"Moustakas","year":"2009","journal-title":"Development"},{"issue":"6958","key":"10.1016\/j.cyto.2025.157090_bb0085","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cyto.2025.157090_bb0090","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2853","article-title":"TGFbeta signalling: a complex web in cancer progression","volume":"10","author":"Ikushima","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0100","doi-asserted-by":"crossref","first-page":"djt369","DOI":"10.1093\/jnci\/djt369","article-title":"TGF-\u03b2: duality of function between tumor prevention and carcinogenesis","volume":"106","author":"Principe","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cyto.2025.157090_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116646","article-title":"Exploring the potential of TGF\u03b2 as a diagnostic marker and therapeutic target against cancer","volume":"231","author":"Garg","year":"2025","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.cyto.2025.157090_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112767","article-title":"TGF-\u03b2-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis","volume":"20","author":"Hao","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0115","first-page":"21","article-title":"Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer","volume":"1775","author":"Pardali","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cyto.2025.157090_bb0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.semcancer.2023.08.002","article-title":"Proactive and reactive roles of TGF-\u03b2 in cancer","volume":"95","author":"Kuburich","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.cyto.2025.157090_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/OTT.S493643","article-title":"Exploring TGF-\u03b2 Signaling in Cancer Progression: Prospects and Therapeutic Strategies","volume":"18","author":"Sheikh","year":"2025","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.cyto.2025.157090_bb0130","doi-asserted-by":"crossref","DOI":"10.1007\/s10528-025-11182-4","article-title":"miR-574-3p Regulates Smad\/Snail Signaling to Promote Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Cells","author":"Ai","year":"2025","journal-title":"Biochem Genet"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0135","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1038\/s41598-025-86496-9","article-title":"UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-\u03b2\/SMAD signaling pathway","volume":"15","author":"Yang","year":"2025","journal-title":"Scientific Reports"},{"key":"10.1016\/j.cyto.2025.157090_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101203","article-title":"SMYD2 epigenetically activates BMP4\/SMAD1\/5\/8\/ID3 axis to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma","volume":"67","author":"Wang","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.cyto.2025.157090_bb0145","doi-asserted-by":"crossref","first-page":"1513404","DOI":"10.3389\/fimmu.2025.1513404","article-title":"Targeting stemness pathways modulates macrophage polarization and reprograms the tumor microenvironment","volume":"16","author":"Butkute","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.cyto.2025.157090_bb0150","doi-asserted-by":"crossref","first-page":"1564655","DOI":"10.3389\/fonc.2025.1564655","article-title":"HIF-1\u03b1 modulates pancreatic cancer ECM proteins via the TGF-\u03b21\/Smad signaling pathway introduction","volume":"15","author":"Guo","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.cyto.2025.157090_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117872","article-title":"Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-\u03b2\/Smad pathway","volume":"326","author":"Wang","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0160","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41590-025-02103-z","article-title":"Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGF\u03b2 and activin A suppression","volume":"26","author":"Rea","year":"2025","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2025.157090_bb0165","doi-asserted-by":"crossref","first-page":"4903333","DOI":"10.1155\/2022\/4903333","article-title":"Flavokawain B Weakens Gastric Cancer Progression via the TGF-\u03b21\/SMAD4 Pathway and Attenuates M2 Macrophage Polarization","volume":"2022","author":"Zhu","year":"2022","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0170","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/s41467-023-37515-8","article-title":"Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma","volume":"14","author":"Chung","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.cyto.2025.157090_bb0175","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/2159-8290.CD-15-1347","article-title":"TGF\u03b21-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer","volume":"6","author":"Park","year":"2016","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0180","doi-asserted-by":"crossref","first-page":"21533","DOI":"10.1038\/s41598-025-08686-9","article-title":"Simvastatin inhibits the immunosuppressive effects of endometrial cancer-associated mesenchymal stem cells through TGF-\u03b22\/SMAD2\/3 signaling and reduces tumor growth","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0185","doi-asserted-by":"crossref","first-page":"524","DOI":"10.7150\/ijbs.102381","article-title":"Smad2 Cooperating with TGIF2 Contributes to EMT and Cancer Stem Cells Properties in Pancreatic Cancer via Co-Targeting SOX2","volume":"21","author":"Zu","year":"2025","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.cyto.2025.157090_bb0190","article-title":"Expression of the Immune Checkpoint Protein VISTA Is Differentially Regulated by the TGF-\u03b21 - Smad3 Signaling Pathway in Rapidly Proliferating Human Cells and T Lymphocytes","volume":"9","author":"Schlichtner","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31520","article-title":"SMAD4 Regulates the Expression of LCK Affecting Chimeric Antigen Receptor-T Cells Proliferation Through PI3K\/Akt Signaling Pathway","volume":"240","author":"Wan","year":"2025","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cyto.2025.157090_bb0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.molimm.2025.05.017","article-title":"LncRNA SNHG12 promotes EMT and metastasis of colorectal cancer via regulating TGF-\u03b2\/Smad2\/3 signaling pathway","volume":"183","author":"Zhao","year":"2025","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11064-025-04352-8","article-title":"Regulation of Glycolysis by SMAD5 in Glioma Cells: Implications for Tumor Growth and Apoptosis","volume":"50","author":"Zhang","year":"2025","journal-title":"Neurochem Res"},{"key":"10.1016\/j.cyto.2025.157090_bb0210","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22474","article-title":"Distinct modes of SMAD2 chromatin binding and remodeling shape the transcriptional response to NODAL\/Activin signaling","volume":"6","author":"Coda","year":"2017","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2008.302","article-title":"Signaling cross-talk between TGF-beta\/BMP and other pathways","volume":"19","author":"Guo","year":"2009","journal-title":"Cell Res"},{"issue":"12","key":"10.1016\/j.cyto.2025.157090_bb0220","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nrm2297","article-title":"TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility","volume":"8","author":"Schmierer","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.cyto.2025.157090_bb0225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.cyto.2025.157090_bb0230","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.febslet.2012.05.010","article-title":"Post-translational regulation of TGF-\u03b2 receptor and Smad signaling","volume":"586","author":"Xu","year":"2012","journal-title":"FEBS Lett"},{"issue":"9","key":"10.1016\/j.cyto.2025.157090_bb0235","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.tcb.2017.04.005","article-title":"Transforming Growth Factor-\u03b2 Receptors and Smads: Regulatory Complexity and Functional Versatility","volume":"27","author":"Budi","year":"2017","journal-title":"Trends Cell Biol"},{"issue":"Pt 24","key":"10.1016\/j.cyto.2025.157090_bb0240","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1242\/jcs.114.24.4359","article-title":"Smad regulation in TGF-beta signal transduction","volume":"114","author":"Moustakas","year":"2001","journal-title":"J Cell Sci"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030487","article-title":"TGF-\u03b2 Signaling","volume":"10","author":"Tzavlaki","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0250","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1074\/jbc.M115.694281","article-title":"Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-\u03b2 (TGF-\u03b2)\/Smad Signaling","volume":"291","author":"Yan","year":"2016","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.cyto.2025.157090_bb0255","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors","volume":"19","author":"Massagu\u00e9","year":"2005","journal-title":"Genes Dev"},{"issue":"8","key":"10.1016\/j.cyto.2025.157090_bb0260","first-page":"2722","article-title":"Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression","volume":"118","author":"Hoot","year":"2008","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.cyto.2025.157090_bb0265","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/labinvest.2012.47","article-title":"Gastric tumor development in Smad3-deficient mice initiates from forestomach\/glandular transition zone along the lesser curvature","volume":"92","author":"Nam","year":"2012","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0270","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-\u03b2 signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Research"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0275","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022129","article-title":"Non-Smad Signaling Pathways of the TGF-\u03b2 Family","volume":"9","author":"Zhang","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.cyto.2025.157090_bb0280","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2019.11.013","article-title":"Non-canonical (non-SMAD2\/3) TGF-\u03b2 signaling in fibrosis: Mechanisms and targets","volume":"101","author":"Finnson","year":"2020","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0285","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.cyto.2025.157090_bb0290","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021873","article-title":"TGF-\u03b2 and the TGF-\u03b2 Family: Context-Dependent Roles in Cell and Tissue Physiology","volume":"8","author":"Morikawa","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"10.1016\/j.cyto.2025.157090_bb0295","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.molcel.2008.09.002","article-title":"TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta","volume":"31","author":"Yamashita","year":"2008","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0300","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ceb.2009.01.021","article-title":"Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition","volume":"21","author":"Heldin","year":"2009","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0305","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41420-024-02185-y","article-title":"Non-canonical translation in cancer: significance and therapeutic potential of non-canonical ORFs, m(6)A-modification, and circular RNAs","volume":"10","author":"Deng","year":"2024","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0310","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12967-024-05411-4","article-title":"TGF-\u03b2 signaling: critical nexus of fibrogenesis and cancer","volume":"22","author":"Giarratana","year":"2024","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0315","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-023-01847-2","article-title":"circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-\u03b2 signalling pathway-mediated activation of MMPs in pancreatic cancer","volume":"22","author":"Zhao","year":"2023","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020428","article-title":"Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio\/Chemoresistance","volume":"9","author":"Dudas","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0325","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12964-024-01957-4","article-title":"The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors","volume":"22","author":"Liaghat","year":"2024","journal-title":"Cell Communication and Signaling"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0330","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4143\/crt.2012.44.3.151","article-title":"Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer","volume":"44","author":"Nurwidya","year":"2012","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.cyto.2025.157090_bb0335","doi-asserted-by":"crossref","first-page":"1503133","DOI":"10.3389\/fonc.2025.1503133","article-title":"Fruquintinib inhibits the migration and invasion of colorectal cancer cells by modulating epithelial-mesenchymal transition via TGF-\u03b2\/Smad signaling pathway","volume":"15","author":"Song","year":"2025","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0340","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/mc.23484","article-title":"The TGF-\u03b2\/Smad(2\/3) signaling pathway is involved in Musashi2-induced invasion and metastasis of colorectal cancer","volume":"62","author":"Yu","year":"2023","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.cyto.2025.157090_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111680","article-title":"FOXC1 promotes EMT and colorectal cancer progression by attracting M2 macrophages via the TGF-\u03b2\/Smad2\/3\/snail pathway","volume":"130","author":"Zhang","year":"2025","journal-title":"Cell Signal"},{"key":"10.1016\/j.cyto.2025.157090_bb0350","doi-asserted-by":"crossref","first-page":"1562976","DOI":"10.3389\/fonc.2025.1562976","article-title":"Tricellulin facilitates colorectal cancer metastasis through activation of the TGF\u03b2\/SMAD2\/3 signalling pathway","volume":"15","author":"Yang","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.cyto.2025.157090_bb0355","doi-asserted-by":"crossref","first-page":"8639791","DOI":"10.1155\/2019\/8639791","article-title":"MnTE-2-PyP Attenuates TGF-\u03b2-Induced Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Inhibiting the Smad2\/3 Signaling Pathway","volume":"2019","author":"Yang","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0360","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/cas.15560","article-title":"CDCA7 promotes TGF-\u03b2-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4\/Smad7 in ESCC","volume":"114","author":"Li","year":"2023","journal-title":"Cancer Sci"},{"issue":"5","key":"10.1016\/j.cyto.2025.157090_bb0365","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00405-025-09328-6","article-title":"AGR2 activates the TGF-\u03b2\/Smad signaling pathway to promote epithelial-mesenchymal transition, invasion, and metastasis in nasopharyngeal carcinoma","volume":"282","author":"Jin","year":"2025","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0370","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","article-title":"RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-\u03b2 signaling pathway and promoting EMT in ovarian cancer","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov"},{"issue":"8_Supplement_1","key":"10.1016\/j.cyto.2025.157090_bb0375","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1158\/1538-7445.AM2025-2651","article-title":"Nuclear prothymosin \u03b1 suppresses TGF-\u03b2-induced EMT by stabilizing smad7: implications for lung cancer progression and metastasis","volume":"85","author":"Su","year":"2025","journal-title":"Cancer Research"},{"key":"10.1016\/j.cyto.2025.157090_bb0380","doi-asserted-by":"crossref","unstructured":"J. Cai, L. Xia, J. Li, S. Ni, H. Song, X. Wu, Tumor-Associated Macrophages Derived TGF-\u03b2\u2013Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4\/Snail Signaling Pathway, Cancer Res Treat 51(1) (2019) 252-266.","DOI":"10.4143\/crt.2017.613"},{"key":"10.1016\/j.cyto.2025.157090_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.70074","article-title":"Endoglin mediates the tumor- and metastasis-promoting traits of stromal myofibroblasts in human breast carcinomas","volume":"19","author":"Okubo","year":"2025","journal-title":"Mol Oncol"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0390","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/ph17030326","article-title":"Targeting SMAD-dependent signaling: considerations in epithelial and mesenchymal solid tumors","volume":"17","author":"Runa","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0395","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bbrc.2019.11.039","article-title":"Glycosylation is a novel TGF\u03b21-independent post-translational modification of Smad2","volume":"521","author":"Gotoh","year":"2020","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.cyto.2025.157090_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216526","article-title":"POH1 induces Smad3 deubiquitination and promotes lung cancer metastasis","volume":"582","author":"Yuan","year":"2024","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0405","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12935-025-03822-x","article-title":"OTUD3 inhibits breast cancer cell metastasis by regulating TGF-\u03b2 pathway through deubiquitinating SMAD7","volume":"25","author":"Geng","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0410","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41416-025-02970-1","article-title":"SMAD2 linker phosphorylation impacts overall survival, proliferation, TGF\u03b21-dependent gene expression and pluripotency-related proteins in NSCLC","volume":"133","author":"Nitschkowski","year":"2025","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0415","doi-asserted-by":"crossref","first-page":"2478670","DOI":"10.1080\/15384047.2025.2478670","article-title":"PCK2 promotes invasion and epithelial-to-mesenchymal transition in triple-negative breast cancer by promoting TGF-\u03b2\/SMAD3 signaling through inhibiting TRIM67-mediated SMAD3 ubiquitination","volume":"26","author":"Chang","year":"2025","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.cyto.2025.157090_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.593310","article-title":"The Smad Dependent TGF-\u03b2 and BMP Signaling Pathway in Bone Remodeling and Therapies","volume":"8","author":"Zou","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.cyto.2025.157090_bb0425","first-page":"136","article-title":"TGF-\u03b2 in developmental and fibrogenic EMTs, Seminars in cancer biology","author":"Lee","year":"2022","journal-title":"Elsevier"},{"issue":"17","key":"10.1016\/j.cyto.2025.157090_bb0430","article-title":"SMAD Proteins in TGF-\u03b2 Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications","volume":"13","author":"Wang","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"10.1016\/j.cyto.2025.157090_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101130","article-title":"The Interactivity between TGF\u03b2 and BMP Signaling in Organogenesis, Fibrosis, and Cancer","volume":"8","author":"Dituri","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0440","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12935-024-03353-x","article-title":"Smad2\/3\/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma","volume":"24","author":"Li","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167696","article-title":"Programmed cell death protein 5 inhibits hepatocellular carcinoma progression by inducing pyroptosis through regulation of TGF-\u03b2\/Smad2\/3\/Snail pathway","volume":"1871","author":"Wang","year":"2025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0450","doi-asserted-by":"crossref","first-page":"2490346","DOI":"10.1080\/2162402X.2025.2490346","article-title":"Smad7 is a negative regulator of immunogenic cell death in colorectal cancer","volume":"14","author":"Maresca","year":"2025","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0455","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00018-024-05290-4","article-title":"Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production","volume":"81","author":"Lian","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"30","key":"10.1016\/j.cyto.2025.157090_bb0460","doi-asserted-by":"crossref","first-page":"eabo4577","DOI":"10.1126\/sciadv.abo4577","article-title":"SMAD4, activated by the TCR-triggered MEK\/ERK signaling pathway, critically regulates CD8(+) T cell cytotoxic function","volume":"8","author":"Liu","year":"2022","journal-title":"Sci Adv"},{"issue":"20","key":"10.1016\/j.cyto.2025.157090_bb0465","article-title":"KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer","volume":"8","author":"Yu","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.cyto.2025.157090_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.932412","article-title":"Smad4-deficient T cells promote colitis-associated colon cancer via an IFN-\u03b3-dependent suppression of 15-hydroxyprostaglandin dehydrogenase","volume":"13","author":"Choi","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2025.157090_bb0475","doi-asserted-by":"crossref","first-page":"105","DOI":"10.21037\/atm.2019.01.42","article-title":"NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives","volume":"7","author":"Lo Nigro","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.cyto.2025.157090_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106932","article-title":"NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances","volume":"270","author":"Greppi","year":"2024","journal-title":"Immunology Letters"},{"issue":"6","key":"10.1016\/j.cyto.2025.157090_bb0485","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.4049\/jimmunol.181.6.3784","article-title":"TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells","volume":"181","author":"Trotta","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0490","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1038\/ncomms14677","article-title":"Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development","volume":"8","author":"Tang","year":"2017","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0495","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1038\/s41467-024-46778-8","article-title":"BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3","volume":"15","author":"Reggiani","year":"2024","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.cyto.2025.157090_bb0500","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1172\/JCI121227","article-title":"SMAD4 promotes TGF-\u03b2-independent NK cell homeostasis and maturation and antitumor immunity","volume":"128","author":"Wang","year":"2018","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.cyto.2025.157090_bb0505","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.ymthe.2018.06.016","article-title":"Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3\/Smad7 Signaling","volume":"26","author":"Lian","year":"2018","journal-title":"Mol Ther"},{"issue":"17","key":"10.1016\/j.cyto.2025.157090_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36839","article-title":"Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention","volume":"10","author":"Shao","year":"2024","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.cyto.2025.157090_bb0515","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41423-024-01232-z","article-title":"Targeting of TAMs: can we be more clever than cancer cells?","volume":"21","author":"Kzhyshkowska","year":"2024","journal-title":"Cellular & Molecular Immunology"},{"issue":"11","key":"10.1016\/j.cyto.2025.157090_bb0520","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","article-title":"The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy","volume":"10","author":"Yang","year":"2020","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0525","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","article-title":"Targeting tumor-associated macrophages for cancer treatment","volume":"12","author":"Li","year":"2022","journal-title":"Cell Biosci"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0530","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0535","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming Growth Factor-\u03b2 Signaling in Immunity and Cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cyto.2025.157090_bb0540","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol"},{"issue":"15","key":"10.1016\/j.cyto.2025.157090_bb0545","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.7150\/ijbs.98529","article-title":"Smad4 Deficiency in S100A4(+) Macrophages Enhances Colitis-associated Tumorigenesis by Promoting Macrophage Lipid Metabolism Augmented M2 Polarization","volume":"20","author":"Liu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.cyto.2025.157090_bb0550","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.freeradbiomed.2024.11.028","article-title":"Cold atmospheric plasma restores skewed macrophage polarization in triple negative breast cancers via enhancing KAT6A acetylation","volume":"226","author":"Zhu","year":"2025","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0555","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0560","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","article-title":"Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion","volume":"13","author":"Lu","year":"2024","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030561","article-title":"Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer","volume":"9","author":"Law","year":"2020","journal-title":"Cells"},{"issue":"88","key":"10.1016\/j.cyto.2025.157090_bb0570","doi-asserted-by":"crossref","first-page":"eadh1306","DOI":"10.1126\/sciimmunol.adh1306","article-title":"BCL6 promotes a stem-like CD8(+) T cell program in cancer via antagonizing BLIMP1","volume":"8","author":"Sun","year":"2023","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0575","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001469","article-title":"Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer","volume":"9","author":"Marwitz","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0580","article-title":"CD4(+) anti-TGF-\u03b2 CAR T cells and CD8(+) conventional CAR T cells exhibit synergistic antitumor effects","volume":"6","author":"Zheng","year":"2025","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0585","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12935-024-03525-9","article-title":"Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?","volume":"24","author":"Anvar","year":"2024","journal-title":"Cancer Cell International"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0590","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12943-016-0551-1","article-title":"Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis","volume":"15","author":"Marshall","year":"2016","journal-title":"Molecular Cancer"},{"issue":"9","key":"10.1016\/j.cyto.2025.157090_bb0595","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41590-024-01909-7","article-title":"An intestinal T(H)17 cell-derived subset can initiate cancer","volume":"25","author":"Fesneau","year":"2024","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2025.157090_bb0600","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-025-01281-y","article-title":"The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs","volume":"22","author":"Accogli","year":"2025","journal-title":"Cell Mol Immunol"},{"issue":"06","key":"10.1016\/j.cyto.2025.157090_bb0605","article-title":"Anti-activin treatment increases T cell infiltration in breast and pancreatic tumours and promotes survival in a SMAD4-null mouse pancreatic cancer model","volume":"2025","author":"McCluney","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0610","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.cyto.2025.157090_bb0615","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1511560","article-title":"Expanding horizons of cancer immunotherapy: hopes and hurdles","volume":"15","author":"Sonar","year":"2025","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.cyto.2025.157090_bb0620","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1158\/1078-0432.CCR-19-2034","article-title":"Radiotherapy and Immunotherapy for Cancer: From \"Systemic\" to \"Multisite\"","volume":"26","author":"Arina","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0625","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011829","article-title":"MARC, a novel modular chimeric antigen receptor, improves T cell-based cancer immunotherapies by preventing early T cell exhaustion and enhancing persistence","volume":"13","author":"Tual","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"5","key":"10.1016\/j.cyto.2025.157090_bb0630","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.ymthe.2025.03.005","article-title":"From concept to cure: The evolution of CAR-T cell therapy","volume":"33","author":"Patel","year":"2025","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0635","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011734","article-title":"Tumor-infiltrating lymphocyte immunotherapy comes of age: a journey of development in the Surgery Branch, NCI","volume":"13","author":"Goff","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.cyto.2025.157090_bb0640","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s43018-025-01020-2","article-title":"Tumor-infiltrating lymphocyte therapies in gastrointestinal cancer","volume":"6","author":"Giacco","year":"2025","journal-title":"Nature Cancer"},{"key":"10.1016\/j.cyto.2025.157090_bb0645","series-title":"CANCER IMMUNOLOGY RESEARCH, AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA","article-title":"Development of monoclonal antibodies targeting truncated O-glycans expressed specifically by cancer cells offers a novel strategy to enhance cancer immunotherapy efficacy","author":"Fantini","year":"2025"},{"issue":"6","key":"10.1016\/j.cyto.2025.157090_bb0650","article-title":"A Comprehensive Review of Monoclonal Antibodies in Modern Medicine: Tracing the Evolution of a Revolutionary Therapeutic Approach","volume":"16","author":"Kothari","year":"2024","journal-title":"Cureus"},{"issue":"Pt 2","key":"10.1016\/j.cyto.2025.157090_bb0655","article-title":"A comprehensive review of immune checkpoint inhibitors for cancer treatment","volume":"143","author":"Arafat Hossain","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0660","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41423-024-01245-8","article-title":"Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors","volume":"22","author":"Catanzaro","year":"2025","journal-title":"Cellular & Molecular Immunology"},{"issue":"5","key":"10.1016\/j.cyto.2025.157090_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/genes14051008","article-title":"The Interplay between T Cells and Cancer: The Basis of Immunotherapy","volume":"14","author":"Chen","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.cyto.2025.157090_bb0670","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1264327","article-title":"Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors","volume":"14","author":"Roy","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0675","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.gastro.2023.10.026","article-title":"An NFATc1\/SMAD3\/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies","volume":"166","author":"Hasselluhn","year":"2024","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0680","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.chembiol.2023.10.024","article-title":"Genetic retargeting of E3 ligases to enhance CAR T cell therapy","volume":"31","author":"Lane","year":"2024","journal-title":"Cell Chem Biol"},{"issue":"9","key":"10.1016\/j.cyto.2025.157090_bb0685","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/resp.14541","article-title":"Overexpression of SMAD7 improves the function of EGFR-targeted human CAR-T cells against non-small-cell lung cancer","volume":"28","author":"Li","year":"2023","journal-title":"Respirology"},{"key":"10.1016\/j.cyto.2025.157090_bb0690","first-page":"1154","article-title":"Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer, Comput Struct","volume":"20","author":"Wang","year":"2022","journal-title":"Biotechnol J"},{"issue":"7","key":"10.1016\/j.cyto.2025.157090_bb0695","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165544","article-title":"TGF-\u03b21 induces PD-1 expression in macrophages through SMAD3\/STAT3 cooperative signaling in chronic inflammation","volume":"9","author":"Lei","year":"2024","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.cyto.2025.157090_bb0700","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1038\/s41418-021-00781-4","article-title":"PLK1\/vimentin signaling facilitates immune escape by recruiting Smad2\/3 to PD-L1 promoter in metastatic lung adenocarcinoma","volume":"28","author":"Jang","year":"2021","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0705","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12931-019-1137-4","article-title":"The canonical TGF-\u03b2\/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer","volume":"20","author":"Zhang","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.cyto.2025.157090_bb0710","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.806963","article-title":"Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer","volume":"12","author":"Principe","year":"2022","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.cyto.2025.157090_bb0715","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1172\/JCI92167","article-title":"Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity","volume":"127","author":"Watanabe","year":"2017","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1016\/j.cyto.2025.157090_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111878","article-title":"The loss of epithelial Smad4 drives immune evasion via CXCL1 while displaying vulnerability to combinatorial immunotherapy in gastric cancer","volume":"41","author":"An","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.cyto.2025.157090_bb0725","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1158\/0008-5472.CAN-24-1970","article-title":"SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGF\u03b2 Inhibition","volume":"85","author":"Murimwa","year":"2025","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0730","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxae108","article-title":"Exploring the relation between TGF-\u03b2 pathway activity and response to checkpoint inhibition in patients with metastatic melanoma","volume":"219","author":"van Ravensteijn","year":"2025","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0735","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41423-023-01120-y","article-title":"SMAD7 expression in CAR-T cells improves persistence and safety for solid tumors","volume":"21","author":"Liang","year":"2024","journal-title":"Cell Mol Immunol"},{"issue":"5-6","key":"10.1016\/j.cyto.2025.157090_bb0740","doi-asserted-by":"crossref","first-page":"134","DOI":"10.18632\/genesandcancer.194","article-title":"Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-\u03b2 from growth suppressor to growth and metastasis promoter through TMEPAI\/PMEPA1 in triple negative breast cancer","volume":"10","author":"Singha","year":"2019","journal-title":"Genes Cancer"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0745","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41374-020-00517-x","article-title":"SMAD4 mutation correlates with poor prognosis in non-small cell lung cancer","volume":"101","author":"Wang","year":"2021","journal-title":"Lab Invest"},{"key":"10.1016\/j.cyto.2025.157090_bb0750","doi-asserted-by":"crossref","first-page":"1139203","DOI":"10.3389\/fmed.2023.1139203","article-title":"The effect of SMAD4 on the prognosis and immune response in hypopharyngeal carcinoma","volume":"10","author":"Song","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0755","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s11033-024-09697-x","article-title":"Investigating the impact of SMAD2 and SMAD4 downregulation in colorectal cancer and their correlation with immune markers, prognosis, and drug resistance and sensitivity","volume":"51","author":"Amani","year":"2024","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0760","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41598-024-84553-3","article-title":"Multiomic characterization, immunological and prognostic potential of SMAD3 in pan-cancer and validation in LIHC","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0765","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00262-025-03948-x","article-title":"Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients","volume":"74","author":"Fu","year":"2025","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0770","article-title":"Smad1 Promotes Tumorigenicity and Chemoresistance of Glioblastoma by Sequestering p300 From p53","volume":"12","author":"Gong","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.cyto.2025.157090_bb0775","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/cas.70109","article-title":"TGF-\u03b2 Enhances Doxorubicin Resistance and Anchorage-Independent Growth in Cancer Cells by Inducing ALDH1A1 Expression","volume":"116","author":"Yokoyama","year":"2025","journal-title":"Cancer Sci"},{"issue":"9","key":"10.1016\/j.cyto.2025.157090_bb0780","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.7150\/ijbs.43117","article-title":"USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2","volume":"16","author":"Dou","year":"2020","journal-title":"Int J Biol Sci"},{"issue":"10","key":"10.1016\/j.cyto.2025.157090_bb0785","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1158\/1078-0432.CCR-24-0027","article-title":"Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair","volume":"30","author":"Ballout","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0790","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17040610","article-title":"Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT","volume":"17","author":"Zhou","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.cyto.2025.157090_bb0795","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1158\/1078-0432.CCR-18-3791","article-title":"HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma","volume":"25","author":"Li","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.cyto.2025.157090_bb0800","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1007\/s12010-022-04253-4","article-title":"The Interaction Between SMAD1 and YAP1 Is Correlated with Increased Resistance of Gastric Cancer Cells to Cisplatin","volume":"195","author":"Chen","year":"2023","journal-title":"Appl Biochem Biotechnol"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0805","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.gastro.2023.09.021","article-title":"BRD9-SMAD2\/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma","volume":"166","author":"Feng","year":"2024","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cyto.2025.157090_bb0810","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.1002\/jcb.28371","article-title":"SMAD3 inducing the transcription ofSTYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel","volume":"120","author":"Shi","year":"2019","journal-title":"J Cell Biochem"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0815","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target Oncol"},{"key":"10.1016\/j.cyto.2025.157090_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101730","article-title":"Unlocking the potential of non-coding RNAs in cancer research and therapy","volume":"35","author":"Uppaluri","year":"2023","journal-title":"Transl Oncol"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0825","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.cyto.2025.157090_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2020.100844","article-title":"Dysregulation of miR-27a and SMAD2 can be a reliable indicator in the prognosis and diagnosis of CRC as well as in response to chemotherapy drugs","volume":"21","author":"Azar","year":"2020","journal-title":"Gene Reports"},{"issue":"7","key":"10.1016\/j.cyto.2025.157090_bb0835","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071879","article-title":"MiR-216b\/Smad3\/BCL-2 Axis Is Involved in Smoking-Mediated Drug Resistance in Non-Small Cell Lung Cancer","volume":"12","author":"Vu","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0840","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1097\/CAD.0000000000001197","article-title":"Circular RNA circ_0008450 regulates the proliferation, migration, invasion, apoptosis and chemosensitivity of CDDP-resistant nasopharyngeal carcinoma cells by the miR-338-3p\/SMAD5 axis","volume":"33","author":"Liu","year":"2022","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0845","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/13813455.2024.2404099","article-title":"MiR-93 promotes the progression and chemoresistance of diffuse large B-cell lymphoma cells via targeting SMAD5","volume":"131","author":"Fang","year":"2025","journal-title":"Archives of Physiology and Biochemistry"},{"issue":"9","key":"10.1016\/j.cyto.2025.157090_bb0850","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","article-title":"Stromal cells in the tumor microenvironment: accomplices of tumor progression?","volume":"14","author":"Zhao","year":"2023","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0855","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3892\/ijo.2024.5684","article-title":"Drug resistance and tumor immune microenvironment: An overview of current understandings","volume":"65","author":"Liu","year":"2024","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.cyto.2025.157090_bb0860","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241274337","article-title":"Tumor-Associated Macrophage-Derived TGF-\u03b21 Activates GLI2 via the Smad2\/3 Signaling Pathway to Affect Cisplatin Resistance in Lung Adenocarcinoma","volume":"23","author":"Lan","year":"2024","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.cyto.2025.157090_bb0865","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41419-021-03574-2","article-title":"Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-\u03b21\/SMAD2\/3 pathway and ABCC1 transactivation","volume":"12","author":"Wei","year":"2021","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.cyto.2025.157090_bb0870","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1158\/1078-0432.CCR-18-1726","article-title":"SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence","volume":"25","author":"Wasserman","year":"2019","journal-title":"Loss of Immune Infiltrate, and Chemoresistance, Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0875","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1158\/1541-7786.MCR-19-0525","article-title":"Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan","volume":"18","author":"Wong","year":"2020","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.cyto.2025.157090_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102648","article-title":"ADAM17 promotes colorectal cancer migration and invasion by regulating the TGF-\u03b2\/Smad signaling pathway","volume":"93","author":"Li","year":"2025","journal-title":"Tissue and Cell"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0885","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12885-024-11925-3","article-title":"OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-\u03b2\/Smad signaling pathway","volume":"24","author":"Tang","year":"2024","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0890","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10616-025-00765-z","article-title":"ZNF384 mediates KRT23 to promote CRC process through the TGF-\u03b2\/Smad signaling pathway","volume":"77","author":"Liu","year":"2025","journal-title":"Cytotechnology"},{"key":"10.1016\/j.cyto.2025.157090_bb0895","article-title":"Knockdown of TBRG4 suppresses the migration, invasion, and epithelial-to-mesenchymal transition of pancreatic cancer cells via TGF-\u03b2\/smad3 signaling","volume":"18871","author":"Ye","year":"2025","journal-title":"Histol Histopathol"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0900","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10735-025-10373-y","article-title":"Effect of sufentanil on the proliferation, apoptosis, and epithelial-mesenchymal transition of ovarian cancer cells by regulating the SMAD3\/SNAIL signaling pathway","volume":"56","author":"Zhao","year":"2025","journal-title":"J Mol Histol"},{"issue":"5","key":"10.1016\/j.cyto.2025.157090_bb0905","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70486","article-title":"CD39 Contributes to the Ability of Cell Invasion in Heterogeneity of Colorectal Cancer","volume":"29","author":"Li","year":"2025","journal-title":"J Cell Mol Med"},{"issue":"11","key":"10.1016\/j.cyto.2025.157090_bb0910","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17111761","article-title":"The Interplay of SMAD4 and EMT in Oral Squamous Cell Carcinoma","volume":"17","author":"Mozalbat","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cyto.2025.157090_bb0915","doi-asserted-by":"crossref","first-page":"291","DOI":"10.18632\/oncotarget.28717","article-title":"METTL3 promotes oral squamous cell carcinoma by regulating miR-146a-5p\/SMAD4 axis","volume":"16","author":"Jayaprakash","year":"2025","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2025.157090_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117899","article-title":"A novel missense mutation Smad4 V354L enhances the efficacy of docetaxel in non-small cell lung cancer","volume":"184","author":"Xue","year":"2025","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.cyto.2025.157090_bb0925","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3892\/ol.2025.14897","article-title":"MicroRNA-96 promotes the proliferation and migration of breast cancer cells by inhibiting Smad7 expression","volume":"29","author":"Zhang","year":"2025","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0930","article-title":"NSUN5 Facilitates Hepatocellular Carcinoma Progression by Increasing SMAD3 Expression","volume":"12","author":"Han","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.cyto.2025.157090_bb0935","doi-asserted-by":"crossref","first-page":"11584","DOI":"10.1038\/s41598-025-96274-2","article-title":"BMP2 expression in oral squamous cell carcinoma and its effects on SCC9 cell biological behavior","volume":"15","author":"Xing","year":"2025","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.cyto.2025.157090_bb0940","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1515\/oncologie-2024-0534","article-title":"BMPR1A promotes the proliferation of colorectal cancer cells through the activation of Smad1","volume":"27","author":"Zhou","year":"2025","journal-title":"Oncologie"},{"key":"10.1016\/j.cyto.2025.157090_bb0945","first-page":"1154","article-title":"Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer, Computational and Structural","volume":"20","author":"Wang","year":"2022","journal-title":"Biotechnology Journal"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625002376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625002376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:05:03Z","timestamp":1768424703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625002376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":189,"alternative-id":["S1043466625002376"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157090","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMAD signaling in cancer: integrative roles in tumor progression, immune evasion, and therapeutic resistance","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157090"}}